MorphoSys (MOR) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free MOR Stock Alerts $18.35 -0.04 (-0.22%) (As of 09:46 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 3:42 AM | americanbankingnews.comMorphoSys AG (NASDAQ:MOR) Given Consensus Recommendation of "Hold" by BrokeragesMay 15 at 3:41 AM | marketbeat.comMorphoSys AG (NASDAQ:MOR) Receives Consensus Recommendation of "Hold" from AnalystsShares of MorphoSys AG (NASDAQ:MOR - Get Free Report) have received a consensus recommendation of "Hold" from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and three have assigned a buy rMay 14 at 5:26 PM | marketbeat.comMorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.38MorphoSys (NASDAQ:MOR) Sets New 52-Week High at $18.38May 13 at 9:43 PM | marketbeat.comShort Interest in MorphoSys AG (NASDAQ:MOR) Decreases By 18.3%MorphoSys AG (NASDAQ:MOR - Get Free Report) saw a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,250,000 shares, a drop of 18.3% from the April 15th total of 1,530,000 shares. Based on an average daily volume of 1,390,000 shares, the short-interest ratio is presently 0.9 days.May 10, 2024 | finance.yahoo.comMorphoSys (ETR:MOR) shareholders have earned a 228% return over the last yearMay 6, 2024 | finance.yahoo.comMorphoSys AG (MOR2.DU)May 4, 2024 | marketbeat.comHenry James International Management Inc. Takes $426,000 Position in MorphoSys AG (NASDAQ:MOR)Henry James International Management Inc. acquired a new position in shares of MorphoSys AG (NASDAQ:MOR - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 43,000 sharApril 29, 2024 | msn.comMorphoSys reports Q1 resultsApril 29, 2024 | markets.businessinsider.comEQS-News: MorphoSys AG Reports First Quarter 2024 Financial ResultsApril 29, 2024 | marketbeat.comMorphoSys (NASDAQ:MOR) Shares Gap Down to $18.04MorphoSys (NASDAQ:MOR) Shares Gap Down to $18.04April 29, 2024 | uk.investing.comMorphosys says takeover by Novartis on course after report of drug safety concernApril 29, 2024 | benzinga.comMorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, PelabresibApril 29, 2024 | reuters.comMorphosys says Novartis takeover progressing as planned for H1 2024April 28, 2024 | markets.businessinsider.comHere's what to expect from Morphosys's earningsApril 27, 2024 | msn.comGermany stocks higher at close of trade; DAX up 1.39%April 23, 2024 | ca.finance.yahoo.comNovartis lifts guidance after Q1 results beat expectationsApril 23, 2024 | uk.finance.yahoo.comNovartis raises guidance after beating Q1 expectationsApril 13, 2024 | marketbeat.comMorphoSys AG (NASDAQ:MOR) Short Interest Down 22.0% in MarchMorphoSys AG (NASDAQ:MOR - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 1,630,000 shares, a decline of 22.0% from the March 15th total of 2,090,000 shares. Based on an average daily trading volume, of 2,010,000 shares, the days-to-cover ratio is presently 0.8 days.April 11, 2024 | markets.businessinsider.comEQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by NovartisApril 11, 2024 | markets.businessinsider.comMorphoSys Recommends Shareholders Accept Offer By Novartis - Quick FactsApril 11, 2024 | finance.yahoo.comMorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by NovartisApril 11, 2024 | businesswire.comMorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by NovartisApril 11, 2024 | finanznachrichten.deAspermont Limited: Aspermont is Announcing 'Future of Mining Perth': Unveiling Innovations, Sustainability, and Industry Growth!April 11, 2024 | reuters.comNovartis begins tender offer for MorphoSysApril 11, 2024 | globenewswire.comNovartis tender offer for MorphoSys AG commencesMarch 26, 2024 | marketbeat.comMorphoSys AG (NASDAQ:MOR) Receives Consensus Rating of "Hold" from AnalystsMorphoSys AG (NASDAQ:MOR - Get Free Report) has earned a consensus rating of "Hold" from the eight analysts that are currently covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to theMarch 20, 2024 | investing.comMorphoSys AG ADR (MOR)March 16, 2024 | seekingalpha.comMorphoSys AG (MOR) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | uk.investing.comEarnings call: MorphoSys reported a strong performance for 2023March 16, 2024 | ca.finance.yahoo.comNVS Apr 2024 80.000 callMarch 16, 2024 | marketbeat.comHudson Bay Capital Management LP Reduces Position in MorphoSys AG (NASDAQ:MOR)Hudson Bay Capital Management LP cut its position in MorphoSys AG (NASDAQ:MOR - Free Report) by 23.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 455,000 shares of the company's stock after selling 142,March 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exact Sciences Amid Market Expansion and Product Advancement ProspectsMarch 14, 2024 | marketbeat.comMorphoSys' (MOR) "Equal Weight" Rating Reiterated at Wells Fargo & CompanyWells Fargo & Company reaffirmed an "equal weight" rating on shares of MorphoSys in a research note on Thursday.March 14, 2024 | msn.comBiotech Rally Gets $100 Billion M&A Lift With More Deals to ComeMarch 13, 2024 | businesswire.comMorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateMarch 13, 2024 | finance.yahoo.comEltaMD Establishes March 13th as National Dermatologist Day, Building a Healthier Future for AllMarch 12, 2024 | markets.businessinsider.comHere's what Wall Street expects from Morphosys's earningsMarch 12, 2024 | markets.businessinsider.comHere's what Wall Street expects from MorphoSys's earnings reportMarch 12, 2024 | reuters.comGerman competition regulator clears path for Novartis takeover of MorphoSysMarch 12, 2024 | marketbeat.comMorphoSys (NASDAQ:MOR) Sets New 12-Month High at $18.05MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.05March 11, 2024 | finance.yahoo.comThe Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSysMarch 6, 2024 | marketbeat.comMorphoSys (MOR) Set to Announce Quarterly Earnings on WednesdayMorphoSys (NASDAQ:MOR) will be releasing earnings after the market closes on Wednesday, March 13, Zacks reports.February 23, 2024 | marketbeat.comOptiver Holding B.V. Acquires 142,382 Shares of MorphoSys AG (NASDAQ:MOR)Optiver Holding B.V. boosted its stake in MorphoSys AG (NASDAQ:MOR - Free Report) by 8,577.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 144,042 shares of the company's stock after purchasing an additionalFebruary 7, 2024 | marketbeat.comMorphoSys (NASDAQ:MOR) Shares Gap Up to $16.27MorphoSys (NASDAQ:MOR) Shares Gap Up to $16.27February 6, 2024 | benzinga.comDecoding MorphoSys's Options Activity: What's the Big Picture?February 6, 2024 | morningstar.comMorphoSys Shares Jump After It Agrees to $2.9 Billion Takeover by NovartisFebruary 6, 2024 | marketbeat.comMorphoSys (NASDAQ:MOR) Stock Price Down 6%MorphoSys (NASDAQ:MOR) Stock Price Down 6%February 6, 2024 | marketwatch.comMorphoSys Shares Jump After It Agrees to $2.9 Bln Takeover by NovartisFebruary 6, 2024 | msn.comMorphoSys drops amid speculation Novartis could walk from dealFebruary 6, 2024 | finance.yahoo.comNovartis Buys MorphoSys for €2.7 Billion to Get Cancer Drugs Get MorphoSys News Delivered to You Automatically Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016. Get the full story here. MOR Media Mentions By Week MOR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MOR News Sentiment▼0.980.56▲Average Medical News Sentiment MOR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MOR Articles This Week▼53▲MOR Articles Average Week Get MorphoSys News Delivered to You Automatically Sign up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RNA News Today TGTX News Today FOLD News Today ARWR News Today MRVI News Today CORT News Today MRUS News Today BHC News Today MLTX News Today JANX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MOR) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTrump Asset Seizure Threat Alert: Could Your Savings Be Next?American Hartford Gold GroupDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldBiden to Drop BOMBSHELL June 13th?Paradigm PressForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MorphoSys AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
